Cost-effective antimicrobial drug selection for the management and control of respiratory disease in European cattle

Respiratory disease in growing cattle has both animal welfare and economic implications, but the use of antimicrobial drugs to treat and control it is under public scrutiny owing to concerns that their use in food-producing animals may be detrimental to human health. This paper outlines criteria for...

Full description

Saved in:
Bibliographic Details
Published inVeterinary record Vol. 146; no. 19; pp. 545 - 550
Main Author Barrett, D. C.
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Limited 06.05.2000
Blackwell Publishing Ltd
Subjects
Animals
Anti-Bacterial Agents - economics
Anti-Bacterial Agents - therapeutic use
antimicrobial agents
Cattle
Cattle Diseases - drug therapy
Cattle Diseases - microbiology
Cost-Benefit Analysis
costs and returns
Decision Making
Drug Costs
losses
Quality Control
respiratory tract diseases
Respiratory Tract Diseases - drug therapy
Respiratory Tract Diseases - economics
Respiratory Tract Diseases - veterinary
selection
treatment
Veterinary Drugs - economics
Europe
Online AccessGet full text

Cover

More Information
Summary:Respiratory disease in growing cattle has both animal welfare and economic implications, but the use of antimicrobial drugs to treat and control it is under public scrutiny owing to concerns that their use in food-producing animals may be detrimental to human health. This paper outlines criteria for the selection of appropriate and cost-effective drugs, based on good clinical practice and sound economic principles. It also suggests that these principles should be integrated into quality assurance schemes, and that the monitoring of antimicrobial resistance patterns among known bacterial respiratory pathogens should be improved.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0042-4900
2042-7670
DOI:10.1136/vr.146.19.545